Follow-The-Filings

Security · featured owners

TGTX Tg Therapeutics Inc.

COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 2.7%
  • $29M

Who owns this now

Largest portfolio weights among featured holders · max 2.7% (James Silverman - Opaleye...) · not free-float ownership

  1. James Silverman 2.7%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
James Silverman - Opaleye Management 2026 Q2 2.7% Hold 535,000 $29M history

1 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $233.66M $329M $616.29M
Net income $12.67M $23.38M $447.18M
Net margin * 5.4% 7.1% 72.6%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $317.94M $566.36M $630.76M
Total non-current assets * $11.64M $11.33M $432.49M
Total assets $329.59M $577.69M $1.06B
Total current liabilities $53.72M $90.68M $153.76M
Total non-current liabilities * $115.36M $264.65M $261.47M
Total equity $160.5M $222.36M $648.02M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$31.41M -$40.52M -$24.77M
Cash from investing -$50.65M -$1.04M $13.8M
Cash from financing $72.7M $128.53M -$89.73M
Net change in cash -$9.36M $86.97M -$100.7M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders